About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Equity Capital Raising Placement of New Shares
September 1, 2014
Click here to read more
Post navigation
Previous Post
Financial Report for Half Year ended 30 June 2014
Next Post
Phosphagenics Announces Successful Results from its Phase 2 TPM®/Tretinoin Gel Study on Acne Patients
Related Posts
Ashland Purchases Manufacturing Rights for VitalET and TPM
June 20, 2019
August 28, 2019
Phosphagenics Restructures
October 12, 2015
Quarterly Activities Report and 4C
July 27, 2021
July 27, 2021